SOPHiA GENETICS
SOPH
SOPH
32 hedge funds and large institutions have $43.2M invested in SOPHiA GENETICS in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 9 increasing their positions, 10 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
46% less capital invested
Capital invested by funds: $80.2M → $43.2M (-$37M)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Holders
32
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$802K | |
| 2 | +$253K | |
| 3 | +$204K | |
| 4 |
BPC
Banque Pictet & Cie
Geneva 73,
Switzerland
|
+$128K |
| 5 |
Morgan Stanley
New York
|
+$34.9K |
Top Sellers
| 1 | -$4.29M | |
| 2 | -$827K | |
| 3 | -$323K | |
| 4 |
TD Asset Management
Toronto,
Ontario, Canada
|
-$308K |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$140K |